PNPLA3 protein expression is increased in subjects with obesity compared to those without, while the presence of the rs738409 SNP encodes for a loss of function variant that promote triglyceride retention in lipid droplets, favoring the development of hepatic steatosis and enhancing inflammation [109]. Here, PNPLA3 is linked to fatty liver disease.